Neuromuscular blockade for rapid tracheal intubation in children: comparison of succinylcholine and pancuronium

Area of Science:

• Pediatric Anesthesiology
• Pharmacology
• Critical Care Medicine

Background:

• Rapid sequence intubation is crucial for pediatric airway management.
• Choosing the appropriate neuromuscular blocking agent impacts intubation success and safety.
• Succinylcholine and pancuronium are commonly used agents with different onset and duration profiles.

Purpose of the Study:

• To compare the efficacy of succinylcholine and pancuronium for rapid tracheal intubation in pediatric patients.
• To determine the optimal dosage for rapid onset of neuromuscular blockade in children.
• To evaluate the quality of intubating conditions provided by each agent.

Main Methods:

• A prospective study involving 49 healthy children aged 2-8 years undergoing anesthesia.
• Administration of varying doses of succinylcholine (1.0, 1.5 mg/kg) or pancuronium (0.10, 0.15 mg/kg) post-induction.
• Measurement of neuromuscular blockade via thumb adduction force after ulnar nerve stimulation; assessment of intubating conditions.

Main Results:

• Succinylcholine at 1.5 mg/kg yielded the most rapid onset of 95% twitch depression (40.8 ± 3.0 s), followed by 1.0 mg/kg (51.8 ± 14.0 s).
• Pancuronium at 0.15 mg/kg showed intermediate onset (80.3 ± 21.8 s), while 0.10 mg/kg was slowest (150.9 ± 38.0 s).
• Excellent intubating conditions were achieved in 100% with succinylcholine (both doses) and pancuronium 0.15 mg/kg, versus 69% with pancuronium 0.10 mg/kg.

Conclusions:

• Succinylcholine 1.5 mg/kg is the most effective agent for achieving rapid, excellent intubating conditions in pediatric patients.
• Pancuronium 0.15 mg/kg offers a reliable alternative for rapid intubation when succinylcholine is contraindicated.
• Dosage selection is critical for optimizing neuromuscular blockade and intubation success in pediatric anesthesia.